Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women

Journal of the American Geriatrics Society

Volumn 46, Issue 7, 1998, Pages 816-821

  Yaffe, Kristine ^a,c,e   Grady, Deborah ^b,c   Pressman, Alice ^d   Cummings, Steve ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d KAISER PERMANENTE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; ESTRONE;

AGED; AGING; ARTICLE; CASE CONTROL STUDY; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; ESTROGEN BLOOD LEVEL; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PSYCHOMETRY; RADIOIMMUNOASSAY; RISK FACTOR; SCORING SYSTEM;

EID: 0031818145     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1998.tb02713.x     Document Type: Article

References (41)

1. Kimura D. Estrogen replacement therapy may protect against intellectual decline in postmenopausal women. Horm Behav 1995;29:312-321.
2. Robinson D, Friedman L, Marcus R et al. Estrogen replacement therapy and memory in older women. J Am Geriatr Soc 1994;42:919-922.
3. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994;140:256-261.
4. Tang MX, Jacobs D, Stern Y et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429-432.
5. Kawas C, Resnick S, Morrison A et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology 1997;48:1517-1521.
6. Ohkura T, Isse K, Akazawa K et al. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocr J 1994;41(4):361-371.
7. Fillit H, Weinreb H, Cholst I et al. Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type. Psychoneuroendocrinology 1986;11:337-345.
8. McEwen BS, Woolley CS. Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Exp Gerontol 1994;29:431-436.
9. Toran-Allerand C, Miranda RC, Bentham WD et al. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci USA 1992;89:4668-4672.
10. Applebaum-Bowden D, McLean P, Steinmetz A et al. Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women. J Lipid Res 1989;30:1895-1906.
11. Sullivan TJ, Karas RH, Aronovitz M et al. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest 1995;96:2482-2488.
12. Honjo H, Ogino Y, Naitoh K et al. In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer's type). J Steroid Biochem 1989;34:521-525.
13. Cummings SR, Nevitt MC, Browner WS et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995;332:767-773.
14. Magaziner J, Bassett SS, Hebel JR. Predicting performance on the Mini-Mental State Examination. Use of age- and education-specific equations. J Am Geriatr Soc 1987;35:996-1000.
15. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987;48:314-318.
16. Reitan R. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271-276.
17. Wechsler D. Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corporation, 1988.
18. Ganguli M, Belle S, Ratcliff G et al. Sensitivity and specificity for dementia of population-based criteria for cognitive impairment: The MoVIES project. J Gerontol 1993;48:M152-161.
19. Yesavage JA. Geriatric Depression Scale. Psychopharmacol Bull 1988;24:709-711.
20. Kampen DL, Sherwin BB. Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol 1994;83:979-983.
21. Summer BE, Fink G. Estrogen increases the density of 5-hydroxytryptamine (2A) receptors in cerebral cortex and nucleus accumbens in the female rat. J Steroid Biochem Mol Biol 1995;54:15-20.
22. Barrett-Connor E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA 1993;269:2637-2641.
23. Paganini-Hill A, Henderson VW. The effects of hormone replacement therapy, lipoprotein cholesterol levels, and other factors on a clock drawing task in older women. J Am Geriatr Soc 1996;44:818-822.
24. Cauley JA, Cummings SR, Black DM et al. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol 1990;163:1438-1444.
25. Mortimer JA, Graves AB. Education and other socioeconomic determinants of dementia and Alzheimet's disease. Neurology 1993;43(suppl 4):S39-44.
26. Rauramo L, Lagerspetz K, Engblom P, Punnonen R. The effect of castration and peroral estrogen therapy on some psychological functions. Acta Obstet Gynecol Scand Suppl 1976;1976:3-15.
27. Hackman BW, Galbraith D. Replacement therapy and piperazine oestrone sulphate ('Harmogen') and its effect on memory. Curr Med Res Opin 1976;4:303-306.
28. Fedor-Freybcrgh P. The influence of oestrogens on the well being and mental performance in climacteric and postmenopausal women. Acta Obstet Gynecol Scand 1977;64(suppl):1-91.
29. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988;13:345-357.
30. Dirkoff EC, Crary WG, Cristo M, Lobo RA. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 1991;78:991-995.
31. Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992;17:485-495.
32. Campbell S, Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynaecol 1977;4:31-47.
33. Ettinger B, Bainton L, Upmalis DH et al. Comparison of endometrial growth produced by unopposed conjugated estrogens or by micronized estradiol in postmenopausal women. Am J Obstet Gynecol 1997;176:112-117.
34. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 1995;87:190-197.
35. Davidson BJ, Ross RK, Paganini-Hill A et al. Total and free estrogens and androgens in postmenopausal women with hip fractures. J Clin Endocrinol Metab 1982;54:115-120.
36. Lim SK, Won YJ, Lee JH et al. Altered hydroxylation of estrogen in patients with postmenopausal osteopenia. J Clin Endocrinol Metab 1997;82:1001-1006.
37. Vandewalle B, Lefebvre J. Opposite effects of estrogen and catecholestrogen on hormone-sensitive breast cancer cell growth and differentiation. Mol Cell Endocrinol 1989;61:239-246.
38. Wiederholt WC, Cahn D, Butters NM et al. Effects of age, gender and education on selected neuropsychological tests in an elderly community cohort, J Am Geriatr Soc 1993;41:639-647.
39. Hankinson SE, Manson JE, Spiegelman D et al. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomark Prev 1995;4:649-654.
40. Meldrum DR, Davidson BJ, Tataryn IV, Judd HL. Changes in circulating steroids with aging in postmenopausal women. Obstet Gynecol 1981;57:624-628.
41. Ferrini RL, Barrett-Connor E. Caffeine intake and endogenous sex steroid levels in postmenopausal women. The Rancho Bernardo Study. Am J Epidemiol 1996;144:642-644.